BioNTech strengthens cell therapy pipeline with acquisition of R&D platform and US manufacturing facility
BioNTech will acquire Kite’s solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility in Gaithersburg, MD.
Archives for July 20, 2021
Kineta and Samsung Biologics sign agreement for development and manufacture of anti-VISTA antibody immunotherapy
Kineta says the partnership with Samsung Biologics will help it advance its novel anti-VISTA antibody as it aims to start clinical trials next year.